Home Cart Sign in  
Chemical Structure| 1156-19-0 Chemical Structure| 1156-19-0

Structure of Tolazamide
CAS No.: 1156-19-0

Chemical Structure| 1156-19-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Tolazamide is an intermediate-acting, first-generation sulfonylurea with hypoglycemic activity.

Synonyms: U-17835; NSC 70762; Tolazamide, Tolinase, Norglycin, Tolanase, Tolazolamide

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Tolazamide

CAS No. :1156-19-0
Formula : C14H21N3O3S
M.W : 311.40
SMILES Code : O=S(C1=CC=C(C)C=C1)(NC(NN2CCCCCC2)=O)=O
Synonyms :
U-17835; NSC 70762; Tolazamide, Tolinase, Norglycin, Tolanase, Tolazolamide
MDL No. :MFCD00083504
InChI Key :OUDSBRTVNLOZBN-UHFFFAOYSA-N
Pubchem ID :5503

Safety of Tolazamide

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of Tolazamide

RTK

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02456428 - Completed - Canada, Quebec ... More >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less <<
NCT02476760 - Completed - Canada, Quebec ... More >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less <<
NCT02475499 - Completed - Canada, Quebec ... More >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less <<
NCT03492580 - Completed - United States, New Jersey ... More >> Janssen Investigative Site Titusville, New Jersey, United States, 08560 Less <<
NCT01068860 Type 2 Diabetes Mellitus ... More >> Impaired Glucose Tolerance Less << Phase 2 Completed - -
NCT01068860 - Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.21mL

0.64mL

0.32mL

16.06mL

3.21mL

1.61mL

32.11mL

6.42mL

3.21mL

References

 

Historical Records

Categories